A detailed history of Jain Global LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Jain Global LLC holds 45,669 shares of KURA stock, worth $378,596. This represents 0.01% of its overall portfolio holdings.

Number of Shares
45,669
Holding current value
$378,596
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$8.51 - $19.21 $388,643 - $877,301
45,669 New
45,669 $398 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $555M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.